Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.94 USD | +3.16% | -9.54% | +26.72% |
Mar. 20 | North American Morning Briefing : Markets on Hold -2- | DJ |
Mar. 19 | JPMorgan Upgrades Mersana Therapeutics to Neutral From Underweight, Price Target is $5 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.72% | 360M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.55% | 22.15B | |
-17.37% | 21.02B | |
-8.63% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Mersana Therapeutics Gears Up for Milestones in Cancer Drug Trials